Changes of fludeoxyglucose (FDG) PET/CT after subthalamic nucleus deep brain stimulation for Parkinson(s) disease and its clinical significance

doi:10.3969/j.issn.1671-2897.2013.05.015

Home>Articles>Changes of fludeoxyglucose (FDG) PET/CT after subthalamic nucleus deep brain stimulation for Parkinson(s) disease and its clinical significance

DOI: 10.3969/j.issn.1671-2897.2013.05.015

Changes of fludeoxyglucose (FDG) PET/CT after subthalamic nucleus deep brain stimulation for Parkinson(s) disease and its clinical significance

Keywords：Parkinson's diseaseDeep brain stimulationFludeoxyglucosePositron Emission Tomography/Computed Tomography

Publication Date：2013-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 442-445 )

Chinese Journal of Neurosurgical Disease Research

ISTIC

ISSN：1671-2897

Year, Vol.(Issue)：2013,12(5)